Incidence, patient characteristics and predictors of aborted myocardial infarction in patients undergoing primary PCI: Prospective study comparing pre- and in-hospital abciximab pretreatment

EuroIntervention

Volumn 4, Issue 5, 2009, Pages 662-668

  Hassan, Ayman K M ^a,b   Jukema, J Wouter ^a   Van Der Laarse, Arnoud ^a   Hasan Ali, Hosam ^b   Wolterbeek, Ron ^a   Van Der Kley, Frank ^a   Spano, Fabrizio ^a   Atsma, Douwe E ^a   Schalij, Martin J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ASSIUT UNIVERSITY   (Egypt)

Author keywords

Aborted myocardial infarction; Glycoprotein IIb IIIa Antagonist; Percutaneous coronary intervention; ST segment elevation myocardial infarction

Indexed keywords

ABCIXIMAB; ANTITHROMBOCYTIC AGENT; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG ADMINISTRATION; ELECTROCARDIOGRAPHY; EMERGENCY HEALTH SERVICE; FEMALE; HEART INFARCTION; HOSPITAL PATIENT; HUMAN; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RADIOGRAPHY; RISK ASSESSMENT; RISK FACTOR; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; CORONARY ANGIOGRAPHY; DRUG ADMINISTRATION SCHEDULE; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INCIDENCE; INPATIENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 65549108346     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV4I5A110     Document Type: Article

References (15)

1. Antman E, Bassand JP, Klein W, Ohman M, Lopez Sendon JL, Ryden L, Simoons M, Tendera M. Myocardial infarction redefined - a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction: The Joint European Society of Cardiology/American College of Cardiology Committee. J Am Coll Cardiol 2000;36: 959-969.
2. Verheugt FW, Gersh BJ, Armstrong PW. Aborted myocardial infarction: a new target for reperfusion therapy. Eur Heart J 2006;27: 901-904.
3. Weaver WD, Cerqueira M, Hallstrom AP, Litwin PE, Martin JS, Kudenchuk PJ, Eisenberg M. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA 1993;270: 1211-1216.
4. Brouwer MA, Martin JS, Maynard C, Wirkus M, Litwin PE, Verheugt FW, Weaver WD. Influence of early prehospital thrombolysis on mortality and event-free survival (the Myocardial Infarction Triage and Intervention [MITI] Randomized Trial). MITI Project Investigators. Am J Cardiol 1996;78: 497-502.
5. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361: 13-20.
6. Liem SS, van der Hoeven BL, Oemrawsingh PV, Bax JJ, van der Bom JG, Bosch J, Viergever EP, van Rees C, Padmos I, Sedney MI, van Exel HJ, Verwey HF, Atsma DE, van der Velde ET, Jukema JW, van der Wall EE, Schalij MJ. MISSION!: Optimization of acute and chronic care for patients with acute myocardial infarction. Am Heart J 2007;153: 14e1-11.
7. Taher T, Fu Y, Wagner GS, Goodman SG, Fresco C, Granger CB, Wallentin L, van de WF, Verheugt F, Armstrong PW. Aborted myocardial infarction in patients with ST-segment elevation: insights from the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen-3 Trial Electrocardiographic Substudy. J Am Coll Cardiol 2004;44: 38-43.
8. Bruschke AV, van der Laarse A, van der Wall EE. Assessment of the size of acute myocardial infarction. I: Biochemical methods. Cleve Clin J Med 1990;57: 547-550.
9. TIMI Study Group. Definitions used in TIMI trials. http://www.timi.org (7 July 2007).
10. Swets JA. Measuring the accuracy of diagnostic systems. Science 1988;240: 1285-1293.
11. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J 2007;28: 2525-2538.
12. Lamfers EJ, Hooghoudt TE, Uppelschoten A, Stolwijk PW, Verheugt FW. Effect of prehospital thrombolysis on aborting acute myocardial infarction. Am J Cardiol 1999;84: 928-937.
13. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, Hochman JS, Krumholz HM, Kushner FG, Lamas GA, Mullany CJ, Ornato JP, Pearle DL, Sloan MA, Smith SC, Jr., Alpert JS, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Gregoratos G, Halperin JL, Hiratzka LF, Hunt SA, Jacobs AK. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004;110:e82-292.
14. Lamfers EJ, Hooghoudt TE, Hertzberger DP, Schut A, Stolwijk PW, Verheugt FW. Abortion of acute ST segment elevation myocardial infarction after reperfusion: incidence, patients' characteristics, and prognosis. Heart 2003;89: 496-501.
15. Tarantini G, Ramondo A, Iliceto S. Aborted myocardial infarction: a clinical-magnetic resonance correlation. Heart 2005;91:e24.